References

Adams, V. H., McBryant, S. J., Wade, P. A., Woodcock, C. L., & Hansen, J. C. (2007). Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. J Biol Chem, 282 (20), 15057-15064. doi:10.1074/jbc.M700855200
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., . . . Sunyaev, S. R. (2010). A method and server for predicting damaging missense mutations. Nat Methods, 7 (4), 248-249. doi:10.1038/nmeth0410-248
Amir, R. E., Van den Veyver, I. B., Schultz, R., Malicki, D. M., Tran, C. Q., Dahle, E. J., . . . Zoghbi, H. Y. (2000). Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes.Ann Neurol, 47 (5), 670-679.
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet, 23 (2), 185-188. doi:10.1038/13810
Auranen, M., Vanhala, R., Vosman, M., Levander, M., Varilo, T., Hietala, M., . . . Jarvela, I. (2001). MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features. Neurology, 56 (5), 611-617. doi:10.1212/wnl.56.5.611
Ballestar, E., Ropero, S., Alaminos, M., Armstrong, J., Setien, F., Agrelo, R., . . . Esteller, M. (2005). The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. Hum Genet, 116 (1-2), 91-104. doi:10.1007/s00439-004-1200-0
Ballestar, E., Yusufzai, T. M., & Wolffe, A. P. (2000). Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry, 39 (24), 7100-7106.
Bedogni, F., Rossi, R. L., Galli, F., Cobolli Gigli, C., Gandaglia, A., Kilstrup-Nielsen, C., & Landsberger, N. (2014). Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action. Neurosci Biobehav Rev, 46 Pt 2 , 187-201. doi:10.1016/j.neubiorev.2014.01.011
Bhanushali, A. A., Mandsaurwala, A., & Das, B. R. (2016). Homozygous c.1160C>T (P38L) in the MECP2 gene in a female Rett syndrome patient. J Clin Neurosci, 25 , 127-129. doi:10.1016/j.jocn.2015.08.040
Bienvenu, T., Villard, L., De Roux, N., Bourdon, V., Fontes, M., Beldjord, C., . . . French Consortium for, M. G. A. (2002). Spectrum of MECP2 mutations in Rett syndrome. Genet Test, 6 (1), 1-6. doi:10.1089/109065702760093843
Bonino da Silva Santos, L. O., Wilkinson, M., Kuzniar, A., Kaliyaperumal, R., Thompson, M., Dumontier, M., & Burger, K. (2016).Enterprise Interoperability in the Digitized and Networked Factory of the Future - FAIR Data Points Supporting Big Data Interoperability.(M. Zelm;, G. Doumeingts;, & J. P. Mendonça. Eds.): ISTE Press.
Cheadle, J. P., Gill, H., Fleming, N., Maynard, J., Kerr, A., Leonard, H., . . . Clarke, A. (2000). Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet, 9 (7), 1119-1129. doi:10.1093/hmg/9.7.1119
Chen, R., Shi, L., Hakenberg, J., Naughton, B., Sklar, P., Zhang, J., . . . Friend, S. H. (2016). Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases. Nat Biotechnol, 34 (5), 531-538. doi:10.1038/nbt.3514
Christodoulou, J., Grimm, A., Maher, T., & Bennetts, B. (2003). RettBASE: The IRSA MECP2 variation database-a new mutation database in evolution. Hum Mutat, 21 (5), 466-472. doi:10.1002/humu.10194
Das, D. K., Raha, S., Sanghavi, D., Maitra, A., & Udani, V. (2013). Spectrum of MECP2 gene mutations in a cohort of Indian patients with Rett syndrome: report of two novel mutations. Gene, 515 (1), 78-83. doi:10.1016/j.gene.2012.11.024
Dong, C., Wei, P., Jian, X., Gibbs, R., Boerwinkle, E., Wang, K., & Liu, X. (2015). Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies.Hum Mol Genet, 24 (8), 2125-2137. doi:10.1093/hmg/ddu733
Ebert, D. H., Gabel, H. W., Robinson, N. D., Kastan, N. R., Hu, L. S., Cohen, S., . . . Greenberg, M. E. (2013). Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR.Nature, 499 (7458), 341-345. doi:10.1038/nature12348
Ehrhart, F., Coort, S. L., Cirillo, E., Smeets, E., Evelo, C. T., & Curfs, L. M. (2016). Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes. Orphanet J Rare Dis, 11 (1), 158. doi:10.1186/s13023-016-0545-5
Ehrhart, F., Coort, S. L., Eijssen, L., Cirillo, E., Smeets, E. E., Bahram Sangani, N., . . . Curfs, L. M. G. (2018). Integrated analysis of human transcriptome data for Rett syndrome finds a network of involved genes. bioRxiv . doi:10.1101/274258
Ehrhart, F., Sangani, N. B., & Curfs, L. M. G. (2018). Current developments in the genetics of Rett and Rett-like syndrome. Curr Opin Psychiatry, 31 (2), 103-108. doi:10.1097/YCO.0000000000000389
Firth, H. V., Richards, S. M., Bevan, A. P., Clayton, S., Corpas, M., Rajan, D., . . . Carter, N. P. (2009). DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet, 84 (4), 524-533. doi:10.1016/j.ajhg.2009.03.010
Fokkema, I. F., Taschner, P. E., Schaafsma, G. C., Celli, J., Laros, J. F., & den Dunnen, J. T. (2011). LOVD v.2.0: the next generation in gene variant databases. Hum Mutat, 32 (5), 557-563. doi:10.1002/humu.21438
Ghosh, R. P., Horowitz-Scherer, R. A., Nikitina, T., Gierasch, L. M., & Woodcock, C. L. (2008). Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions. J Biol Chem, 283 (29), 20523-20534. doi:10.1074/jbc.M803021200
Heckman, L. D., Chahrour, M. H., & Zoghbi, H. Y. (2014). Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice. Elife, 3 . doi:10.7554/eLife.02676
Horst;, E. v. d., Kaliyaperumal;, R., Tatum;, Z., Thompson;, M., Schultes;, E., Mina;, E., . . . Hoen., P. A. C. t. (2015). Finding novel associations across domains using linked data: a case study on genetic variants disrupting transcription start sites. Proceedings of the 8th International Conference on Semantic Web Applications and Tools for Life Sciences, 1546 .
Huppke, P., Laccone, F., Kramer, N., Engel, W., & Hanefeld, F. (2000). Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet, 9 (9), 1369-1375. doi:10.1093/hmg/9.9.1369
Inui, K., Akagi, M., Ono, J., Tsukamoto, H., Shimono, K., Mano, T., . . . Okada, S. (2001). Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome. Brain Dev, 23 (4), 212-215. doi:10.1016/s0387-7604(01)00197-8
Jacobsen, A., Kaliyaperumal, R., Bonino da Silva Santos, L., Mons, B., Schultes, E., Roos, M., & Thompson, M. (2020). A Generic Workflow for the Data FAIRification Process Data Intelligence, 2 (1-2), 56-65. doi:10.1162/dint_a_00028
Kircher, M., Witten, D. M., Jain, P., O’Roak, B. J., Cooper, G. M., & Shendure, J. (2014). A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet, 46 (3), 310-315. doi:10.1038/ng.2892
Krishnaraj, R., Ho, G., & Christodoulou, J. (2017). RettBASE: Rett syndrome database update. Hum Mutat, 38 (8), 922-931. doi:10.1002/humu.23263
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., . . . Maglott, D. R. (2016). ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res, 44 (D1), D862-868. doi:10.1093/nar/gkv1222
Laurvick, C. L., de Klerk, N., Bower, C., Christodoulou, J., Ravine, D., Ellaway, C., . . . Leonard, H. (2006). Rett syndrome in Australia: a review of the epidemiology. J Pediatr, 148 (3), 347-352. doi:10.1016/j.jpeds.2005.10.037
Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., . . . Exome Aggregation, C. (2016). Analysis of protein-coding genetic variation in 60,706 humans. Nature, 536 (7616), 285-291. doi:10.1038/nature19057
Liu, X., Wu, C., Li, C., & Boerwinkle, E. (2016). dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs. Hum Mutat, 37 (3), 235-241. doi:10.1002/humu.22932
Liyanage, V. R., & Rastegar, M. (2014). Rett syndrome and MeCP2.Neuromolecular Med, 16 (2), 231-264. doi:10.1007/s12017-014-8295-9
Lombardi, L. M., Baker, S. A., & Zoghbi, H. Y. (2015). MECP2 disorders: from the clinic to mice and back. J Clin Invest, 125 (8), 2914-2923. doi:10.1172/JCI78167
Lopes, F., Barbosa, M., Ameur, A., Soares, G., de Sa, J., Dias, A. I., . . . Maciel, P. (2016). Identification of novel genetic causes of Rett syndrome-like phenotypes. J Med Genet, 53 (3), 190-199. doi:10.1136/jmedgenet-2015-103568
Lucariello, M., Vidal, E., Vidal, S., Saez, M., Roa, L., Huertas, D., . . . Esteller, M. (2016). Whole exome sequencing of Rett syndrome-like patients reveals the mutational diversity of the clinical phenotype.Hum Genet, 135 (12), 1343-1354. doi:10.1007/s00439-016-1721-3
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R., Thormann, A., . . . Cunningham, F. (2016). The Ensembl Variant Effect Predictor. Genome Biol, 17 (1), 122. doi:10.1186/s13059-016-0974-4
Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.Nature, 393 (6683), 386-389. doi:10.1038/30764
Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O., . . . Glaze, D. G. (2008). Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology, 70 (16), 1313-1321. doi:10.1212/01.wnl.0000291011.54508.aa
Neul, J. L., Kaufmann, W. E., Glaze, D. G., Christodoulou, J., Clarke, A. J., Bahi-Buisson, N., . . . RettSearch, C. (2010). Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol, 68 (6), 944-950. doi:10.1002/ana.22124
Nielsen, J. B., Henriksen, K. F., Hansen, C., Silahtaroglu, A., Schwartz, M., & Tommerup, N. (2001). MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet, 9 (3), 178-184. doi:10.1038/sj.ejhg.5200600
Percy, A. K., Lane, J. B., Childers, J., Skinner, S., Annese, F., Barrish, J., . . . MacLeod, P. (2007). Rett syndrome: North American database. J Child Neurol, 22 (12), 1338-1341. doi:10.1177/0883073807308715
Percy, A. K., Neul, J. L., Glaze, D. G., Motil, K. J., Skinner, S. A., Khwaja, O., . . . Barnes, K. (2010). Rett syndrome diagnostic criteria: lessons from the Natural History Study. Ann Neurol, 68 (6), 951-955. doi:10.1002/ana.22154
Pizzo, L., Jensen, M., Polyak, A., Rosenfeld, J. A., Mannik, K., Krishnan, A., . . . Girirajan, S. (2018). Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants. Genet Med . doi:10.1038/s41436-018-0266-3
Rett, A. (1966). [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien Med Wochenschr, 116 (37), 723-726.
Sajan, S. A., Jhangiani, S. N., Muzny, D. M., Gibbs, R. A., Lupski, J. R., Glaze, D. G., . . . Neul, J. L. (2017). Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2. Genet Med, 19 (1), 13-19. doi:10.1038/gim.2016.42
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., . . . Ideker, T. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13 (11), 2498-2504. doi:10.1101/gr.1239303
Shihab, H. A., Rogers, M. F., Gough, J., Mort, M., Cooper, D. N., Day, I. N., . . . Campbell, C. (2015). An integrative approach to predicting the functional effects of non-coding and coding sequence variation.Bioinformatics, 31 (10), 1536-1543. doi:10.1093/bioinformatics/btv009
Shovlin, S., & Tropea, D. (2018). Transcriptome level analysis in Rett syndrome using human samples from different tissues. Orphanet J Rare Dis, 13 (1), 113. doi:10.1186/s13023-018-0857-8
Sim, N. L., Kumar, P., Hu, J., Henikoff, S., Schneider, G., & Ng, P. C. (2012). SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res, 40 (Web Server issue), W452-457. doi:10.1093/nar/gks539
Tao, J., Hu, K., Chang, Q., Wu, H., Sherman, N. E., Martinowich, K., . . . Sun, Y. E. (2009). Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci U S A, 106 (12), 4882-4887. doi:10.1073/pnas.0811648106
Thompson, M., Burger, J., Kaliyaperumal, R., Roos, M., & Bonino da Silva Santos, L. (2020). Making FAIR easy with FAIR tools: From creolization to convergence. Data Intelligence, 2 , 87–95. doi:10.1162/dint_a_00031
Tillotson, R., Selfridge, J., Koerner, M. V., Gadalla, K. K. E., Guy, J., De Sousa, D., . . . Bird, A. (2017). Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Nature, 550 (7676), 398-401. doi:10.1038/nature24058
Townend, G. S., Ehrhart, F., van Kranen, H. J., Wilkinson, M., Jacobsen, A., Roos, M., . . . Curfs, L. M. G. (2018). MECP2 variation in Rett syndrome-An overview of current coverage of genetic and phenotype data within existing databases. Hum Mutat, 39 (7), 914-924. doi:10.1002/humu.23542
Vidal, S., Brandi, N., Pacheco, P., Gerotina, E., Blasco, L., Trotta, J. R., . . . Rett Working, G. (2017). The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome. Sci Rep, 7 (1), 12288. doi:10.1038/s41598-017-11620-3
Wan, M., Lee, S. S., Zhang, X., Houwink-Manville, I., Song, H. R., Amir, R. E., . . . Francke, U. (1999). Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet, 65 (6), 1520-1529. doi:10.1086/302690
Wang, J., Tang, J., Lai, M., & Zhang, H. (2014). 5-Hydroxymethylcytosine and disease. Mutat Res Rev Mutat Res, 762 , 167-175. doi:10.1016/j.mrrev.2014.09.003
Weaving, L. S., Williamson, S. L., Bennetts, B., Davis, M., Ellaway, C. J., Leonard, H., . . . Christodoulou, J. (2003). Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet A, 118A (2), 103-114. doi:10.1002/ajmg.a.10053
Wildeman, M., van Ophuizen, E., den Dunnen, J. T., & Taschner, P. E. (2008). Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat, 29 (1), 6-13. doi:10.1002/humu.20654
Zappella, M., Meloni, I., Longo, I., Hayek, G., & Renieri, A. (2001). Preserved speech variants of the Rett syndrome: molecular and clinical analysis. Am J Med Genet, 104 (1), 14-22. doi:10.1002/ajmg.10005